Jul 22, 2026 09:00AM
Jul 15, 2026 01:01AM
Jul 15, 2026 01:00AM
Jul 2, 2026 01:10AM
Jun 30, 2026 01:09AM
Jun 30, 2026 01:09AM
Jun 18, 2026 01:00AM FDA accepts Genentech's application for Lunsumio and Polivy combo
Jun 18, 2026 01:00AM
Jun 11, 2026 01:05AM
Jun 11, 2026 01:05AM
Jun 2, 2026 07:00AM
Jun 2, 2026 01:05AM
May 19, 2026 01:05AM
May 19, 2026 01:05AM Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer
May 15, 2026 12:45PM
May 15, 2026 12:45PM
Apr 30, 2026 01:00AM
Apr 22, 2026 08:30AM
Apr 21, 2026 07:15PM
Apr 21, 2026 11:45AM
Apr 21, 2026 01:00AM FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
Apr 16, 2026 07:00AM
Mar 30, 2026 09:01AM
Mar 30, 2026 09:00AM
Mar 18, 2026 09:00AM
Mar 9, 2026 02:10AM
Mar 6, 2026 08:45AM
Mar 2, 2026 01:10AM Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
Feb 20, 2026 02:00AM
Feb 20, 2026 02:00AM
Feb 20, 2026 01:05AM
Feb 16, 2026 01:00AM
Feb 7, 2026 03:40PM
Dec 22, 2025 01:01AM
Dec 22, 2025 01:00AM FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
Dec 16, 2025 08:30AM
Dec 8, 2025 04:30PM
Nov 10, 2025 01:10AM
Nov 3, 2025 09:00AM
Nov 3, 2025 01:00AM
Oct 28, 2025 02:00AM
Oct 23, 2025 09:00AM Flatiron Health Announces 12 Abstracts Accepted to Be Presented at ISPOR Europe 2025
Oct 20, 2025 01:05AM
Oct 20, 2025 01:01AM
Oct 20, 2025 01:00AM
Oct 16, 2025 11:49AM
Oct 16, 2025 11:45AM
Oct 13, 2025 09:00AM
Oct 13, 2025 01:05AM Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types
Oct 2, 2025 06:30PM

326,211 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All